LEN vs MTVA · rev $34.19B vs $8.8M cap
LEN (LEN) versus MetaVia Inc. (MTVA) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
MetaVia Inc. (MTVA) is a biotechnology company listed on NASDAQ.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
MTVA does not have a complete income-statement cache yet.
LEN currently screens at market cap $0. MTVA currently screens at market cap $8.8M.
Not investment advice. Open the LEN and MTVA stock pages for the full models.
Not investment advice.